From Proteopedia
(Difference between revisions)
proteopedia linkproteopedia link
|
|
| Line 1: |
Line 1: |
| - | [[Image:1osn.jpg|left|200px]] | + | {{Seed}} |
| | + | [[Image:1osn.png|left|200px]] |
| | | | |
| | <!-- | | <!-- |
| Line 9: |
Line 10: |
| | {{STRUCTURE_1osn| PDB=1osn | SCENE= }} | | {{STRUCTURE_1osn| PDB=1osn | SCENE= }} |
| | | | |
| - | '''Crystal structure of Varicella zoster virus thymidine kinase in complex with BVDU-MP and ADP'''
| + | ===Crystal structure of Varicella zoster virus thymidine kinase in complex with BVDU-MP and ADP=== |
| | | | |
| | | | |
| - | ==Overview==
| + | <!-- |
| - | Herpes virus thymidine kinases are responsible for the activation of nucleoside antiviral drugs including (E)-5-(2-bromovinyl)-2'-deoxyuridine. Such viral thymidine kinases (tk), beside having a broader substrate specificity compared with host cell enzymes, also show significant variation in nucleoside phosphorylation among themselves. We have determined the crystal structure of Varicella zoster virus (VZV, human herpes virus 3) thymidine kinase complexed with (E)-5-(2-bromovinyl)-2'-deoxyuridine 5'-monophosphate and ADP. Differences in the conformation of a loop region (residues 55-61) and the position of two alpha-helices at the subunit interface of VZV-tk compared with the herpes simplex virus type 1 (human herpes virus 1) enzyme give rise to changes in the positioning of residues such as tyrosine 66 and glutamine 90, which hydrogen bond to the substrate in the active site. Such changes in combination with the substitution in VZV-tk of two phenylalanine residues (in place of a tyrosine and methionine), which sandwich the substrate pyrimidine ring, cause an alteration in the positioning of the base. The interaction of the (E)-5-(2-bromovinyl)-2'-deoxyuridine deoxyribose ring with the protein is altered by substitution of tyrosine 21 and phenylalanine 139 (analagous to herpes simplex virus type 1 histidine 58 and tyrosine 172), which may explain some of the differences in nucleoside sugar selectivity between both enzymes. The altered active site architecture may also account for the differences in the substrate activity of ganciclovir for the two thymidine kinases. These data should be of use in the design of novel antiherpes and antitumor drugs.
| + | The line below this paragraph, {{ABSTRACT_PUBMED_12686543}}, adds the Publication Abstract to the page |
| | + | (as it appears on PubMed at http://www.pubmed.gov), where 12686543 is the PubMed ID number. |
| | + | --> |
| | + | {{ABSTRACT_PUBMED_12686543}} |
| | | | |
| | ==About this Structure== | | ==About this Structure== |
| Line 34: |
Line 38: |
| | [[Category: Human herpes virus 3]] | | [[Category: Human herpes virus 3]] |
| | [[Category: Thymidine kinase]] | | [[Category: Thymidine kinase]] |
| - | ''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Sat May 3 04:14:11 2008'' | + | |
| | + | ''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Mon Jul 28 09:39:58 2008'' |
Revision as of 06:40, 28 July 2008
Template:STRUCTURE 1osn
Crystal structure of Varicella zoster virus thymidine kinase in complex with BVDU-MP and ADP
Template:ABSTRACT PUBMED 12686543
About this Structure
1OSN is a Single protein structure of sequence from Human herpesvirus 3. Full crystallographic information is available from OCA.
Reference
Crystal structure of varicella zoster virus thymidine kinase., Bird LE, Ren J, Wright A, Leslie KD, Degreve B, Balzarini J, Stammers DK, J Biol Chem. 2003 Jul 4;278(27):24680-7. Epub 2003 Apr 9. PMID:12686543
Page seeded by OCA on Mon Jul 28 09:39:58 2008
